Bergenbio Asa Stock Today

BRRGF Stock  USD 0.97  0.00  0.00%   

Performance

Weakest

 
Weak
 
Strong

Odds Of Distress

High

 
High
 
Low
BerGenBio ASA is trading at 0.97 as of the 30th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.97. BerGenBio ASA has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 30th of November 2025 and ending today, the 30th of December 2025. Click here to learn more.
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the developing drugs to treat immune evasive, drug resistant, and metastatic cancers. The company was incorporated in 2007 and is headquartered in Bergen, Norway. Bergenbio is traded on OTC Exchange in the United States.. The company has 88.66 M outstanding shares. More on BerGenBio ASA

Moving together with BerGenBio Pink Sheet

  0.62ADVWW Advantage SolutionsPairCorr
  0.91PCTTW PureCycle TechnologiesPairCorr
  0.84MAPSW WM TechnologyPairCorr
  0.93GCMGW GCM GrosvenorPairCorr

Moving against BerGenBio Pink Sheet

  0.85TLK Telkom Indonesia TbkPairCorr
  0.83KEP Korea Electric PowerPairCorr
  0.78ATCOL Atlas CorpPairCorr
  0.75EC Ecopetrol SA ADRPairCorr
  0.71PTAIY Astra International TbkPairCorr
  0.68PTITF PT Indosat TbkPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

BerGenBio Pink Sheet Highlights

Business ConcentrationMaterials, Metals & Mining, Biotechnology, Healthcare (View all Sectors)
BerGenBio ASA [BRRGF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 207.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BerGenBio ASA's market, we take the total number of its shares issued and multiply it by BerGenBio ASA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BerGenBio ASA classifies itself under Metals & Mining sector and is part of Materials industry. The entity has 88.66 M outstanding shares. BerGenBio ASA has accumulated about 509.41 M in cash with (303.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BerGenBio ASA Probability Of Bankruptcy
Ownership Allocation
BerGenBio ASA holds a total of 88.66 Million outstanding shares. BerGenBio ASA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BerGenBio Ownership Details

BerGenBio ASA Risk Profiles

BerGenBio Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in BerGenBio ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

BerGenBio ASA Corporate Management

Rune SkeieChief OfficerProfile
Debbie MolyneuxChief OfficerProfile
Nigel MScChief OfficerProfile
Alison MessomDirector OperationsProfile
James BarnesChief OfficerProfile
Cristina MDChief OfficerProfile
Martin OlinChief OfficerProfile

Other Information on Investing in BerGenBio Pink Sheet

BerGenBio ASA financial ratios help investors to determine whether BerGenBio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BerGenBio with respect to the benefits of owning BerGenBio ASA security.